Enhancing immunotherapy response in melanoma: myeloid-derived suppressor cells as a therapeutic targ...
Enhancing immunotherapy response in melanoma: myeloid-derived suppressor cells as a therapeutic target
About this item
Full title
Author / Creator
Publisher
United States: American Society for Clinical Investigation
Journal title
Language
English
Formats
Publication information
Publisher
United States: American Society for Clinical Investigation
Subjects
More information
Scope and Contents
Contents
Despite the remarkable success of immune checkpoint inhibitors (ICIs) in melanoma treatment, resistance to them remains a substantial clinical challenge. Myeloid-derived suppressor cells (MDSCs) represent a heterogeneous population of myeloid cells that can suppress antitumor immune responses mediated by T and natural killer cells and promote tumor...
Alternative Titles
Full title
Enhancing immunotherapy response in melanoma: myeloid-derived suppressor cells as a therapeutic target
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_4b3e03a7c8f1428fab34d0756b6f0292
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4b3e03a7c8f1428fab34d0756b6f0292
Other Identifiers
ISSN
1558-8238,0021-9738
E-ISSN
1558-8238
DOI
10.1172/JCI170762
